NINA FILIP | Medicine and Dentistry | Best Researcher Award

NINA FILIP | Medicine and Dentistry | Best Researcher Award

Assoc. Prof. Dr NINA FILIP, University of Medicine and Pharmacy Grigore T. Popa Iasi, Romania

Filip Nina is an Associate Professor in the Biochemistry Discipline at “Grigore T. Popa” University of Medicine and Pharmacy, Iași, Romania. With over 18 years of academic experience, she has significantly contributed to medical biochemistry education and research. She earned her Ph.D. in Biochemistry from the same institution and holds a Master’s degree in the Biochemistry of Heterocyclic Compounds from Al.I. Cuza University. As a dedicated researcher, she has worked on numerous national and international projects focusing on biochemical and medical research. She is a member of esteemed scientific societies, including the Romanian Association of Laboratory Medicine and the Romanian Society of Biochemistry and Molecular Biology. Throughout her career, she has published several books and research articles, emphasizing her commitment to advancing scientific knowledge. Her expertise spans molecular diagnostics, metabolic biochemistry, and pharmaceutical biochemistry, making her a respected figure in the field.

Publication Profile

google scholar

Education 🎓

Filip Nina holds a Ph.D. in Biochemistry (2005-2009) from “Grigore T. Popa” University of Medicine and Pharmacy, Iași, Romania, where she conducted research in biochemical and medical sciences. She earned a Master’s Degree in Biochemistry of Heterocyclic Compounds (2006-2008) from Al.I. Cuza University, Iași, building expertise in molecular and organic chemistry. Her academic journey began with a Bachelor’s Degree in Chemistry (1998-2002) from the same university, providing a strong foundation in chemical sciences. She has been certified as a Medical Biochemistry Specialist (2010 – Present) and continues to enhance her knowledge in biochemical diagnostics. Her professional development includes a Postgraduate Course in Mineral Metabolism (2006), and advanced training in Hybridization and PCR in Molecular Histopathological Diagnosis (2012) at U.M.F. Grigore T. Popa, Iași. Additionally, she completed a Psychopedagogy Course (2005) at Al.I. Cuza University, Iași, and holds a B2-level English Competence Certificate (2016), further strengthening her academic and research communication skills.

Experience

Filip Nina has a distinguished academic career in biochemistry, currently serving as an Associate Professor (2021-Present) at the Biochemistry Discipline of “Grigore T. Popa” University of Medicine and Pharmacy, Iași, Romania. Prior to this, she held the position of Lecturer (2017-2021) and previously worked as an Assistant Professor (2005-2017) in the same discipline, contributing extensively to teaching, research, and academic development. Her research expertise extends to grant leadership, having served as the Grant Director (2008-2009) for the CNCSIS 282 PN–II–RU–TD–2008-3 project, which explored biogenic amines and their implications in human pathology. Additionally, she was a Research Team Member (2007-2010) for the CNCSIS PN II- ID- No. 223 project, investigating homocysteine’s role in atherogenesis. She has actively participated in national and international research programs, focusing on medical biochemistry and molecular biology, further strengthening her contributions to the scientific and academic communities.

Awards & Honors

Filip Nina has been recognized for her contributions to biochemistry and medical research through several prestigious certifications and awards. She obtained her Medical Biochemistry Specialist Certification (2010), confirmed by MS Order No. 989/05.07.2010, demonstrating her expertise in biochemical diagnostics. Her research leadership includes serving as Grant Director (2008-2009) for the CNCSIS 282 PN–II–RU–TD–2008-3 project on biogenic amines and their role in human pathology. Additionally, she was a Research Grant Member (2007-2010) in the CNCSIS PN II- ID- No. 223 project, studying the involvement of homocysteine in atherogenesis. She holds a Certification in English Proficiency (2016) at the B2 level (Certificate No. 615/9.11.2016), enhancing her international academic communication. Her professional development includes multiple postgraduate certifications in medical teaching, molecular diagnostics, and metabolism. She is also an esteemed member of the Romanian Association of Laboratory Medicine and the Romanian Society of Biochemistry and Molecular Biology, reinforcing her engagement in the scientific community.

Research Focus

Filip Nina’s research focuses on biogenic amines and their implications in human pathology, particularly their role in metabolic and cardiovascular diseases. She has extensively studied homocysteine metabolism and its interference in atherogenic mechanisms, contributing to pharmacobiochemical studies. Her work also covers molecular histopathological diagnostics, utilizing PCR and hybridization techniques to detect metabolic disorders at a cellular level. She has conducted studies on mineral metabolism, emphasizing its impact on enzymatic activities in human biochemistry. As an expert in medical biochemistry, she collaborates on interdisciplinary research exploring biochemical markers in disease diagnosis and treatment strategies. Her work integrates clinical chemistry, enzymology, and pharmaceutical biochemistry, providing valuable insights into disease mechanisms and therapeutic approaches.

Publication Top Notes

  • Biogenic Amines in Human Pathology – A biochemical perspective on metabolic disorders.

  • Homocysteine and Cardiovascular Risk – A pharmacobiochemical study on atherogenesis.

  • Histopathological Molecular Diagnosis using PCR – Applications in metabolic disorders.

  • Mineral Metabolism in Biochemistry – Role in enzyme activity and disease mechanisms.

  • Molecular Biology Techniques in Medical Biochemistry – Advances in clinical diagnostics.

 

Xiangyu Zhong | Medicine | Best Researcher Award

Prof. Xiangyu Zhong | Medicine | Best Researcher Award

Prof. Xiangyu Zhong, The 2nd Affiliated Hospital of Harbin Medical University, China

Professor Xiangyu Zhong is a distinguished academic and chief physician at the Department of General Surgery, The 2nd Affiliated Hospital of Harbin Medical University, China. With a robust background in medicine and extensive clinical experience, his research primarily focuses on cholangiocarcinoma, Metabolic Associated Fatty Liver Disease (MAFLD), and hepatic ischemia-reperfusion injury.

Professional Profiles:

Scopus

Professional Experience:

Prof. Xiangyu Zhong is a distinguished academician with a robust educational background in medicine. He serves as a Professor and Chief Physician in the Department of General Surgery at the Second Affiliated Hospital of Harbin Medical University. With extensive clinical expertise, he has significantly contributed to medical research, particularly in the fields of cholangiocarcinoma, Metabolic Associated Fatty Liver Disease (MAFLD), and hepatic ischemia-reperfusion injury. His academic journey is complemented by 57 publications in SCI/Scopus indexed journals, with a citation index of 1172, solidifying his position as a leading researcher in his field.

Research Interests:

Prof. Zhong’s research is focused on cholangiocarcinoma, MAFLD, and hepatic ischemia-reperfusion injury. His work has substantially enhanced the understanding of these diseases, offering valuable insights into their pathogenesis and potential therapeutic approaches. With three ongoing research projects, his contributions continue to shape the future of clinical treatments and patient care in liver diseases. Although there are no consultancy or industry projects, Prof. Zhong’s research alone has garnered significant recognition, evidenced by his numerous publications and citation index. His contributions have directly impacted advancements in surgical techniques and liver disease management.

Contributions and Impact:

Prof. Zhong’s impactful research has led to significant advancements in understanding complex liver diseases such as cholangiocarcinoma, MAFLD, and hepatic ischemia-reperfusion injury. His work, which has been cited over 1,100 times, is widely recognized for providing new insights and therapeutic approaches that directly benefit patient care. The depth of his research has influenced both the scientific community and clinical practices, furthering knowledge in areas critical for the treatment of liver-related ailments. With a high citation index and numerous peer-reviewed publications, his work continues to drive innovation in liver surgery and related fields.

Publications:

Circ_0007534 Promotes Cholangiocarcinoma Stemness and Resistance to Anoikis through DDX3X-Mediated Positive Feedback Regulation of Parental Gene DDX42
Liu, S., Guan, C., Sha, X., Zhong, X., Jiang, X.
Cellular Signalling, 2024, 118, 111141

Open access

0 citations

Utilization of 3D Printing Technology in Hepatopancreatobiliary Surgery
Shi, W., Wang, J., Gao, J., Cui, Y., Zhong, X.
Journal of Zhejiang University: Science B, 2024, 25(2), pp. 123–134

Open access

1 citation

Forkhead Box O1 in Metabolic Dysfunction-Associated Fatty Liver Disease: Molecular Mechanisms and Drug Research
Sha, X., Zou, X., Liu, S., Zhong, X., Jiang, X.
Frontiers in Nutrition, 2024, 11, 1426780

Open access

1 citation

Research Progress and Applications of Epigenetic Biomarkers in Cancer
Gao, J., Shi, W., Wang, J., Zhong, X., Cui, Y.
Frontiers in Pharmacology, 2024, 15, 1308309

Open access

1 citation

Advances in Drug Therapy for Metastatic Pancreatic Ductal Adenocarcinoma
Gao, J., Wang, J., Guan, C., Xu, X., Zhong, X.
Journal of Cancer, 2024, 15(8), pp. 2214–2228

Open access

0 citations

Ferroptosis: New Strategies and Ideas for the Treatment of Pancreatic Ductal Adenocarcinoma
Yang, C., Dong, Q., Bao, H., Xu, Y., Zhong, X.
Frontiers in Bioscience – Landmark, 2024, 29(1), 45

Open access

0 citations

Cullin-Associated and Neddylation-Dissociated Protein 1 (CAND1) Alleviates NAFLD by Reducing Ubiquitinated Degradation of ACAA2
Huang, X., Liu, X., Li, X., Yang, B., Pan, Z.
Nature Communications, 2023, 14(1), 4620

Open access

5 citations

Retraction: The Prognostic Potential and Carcinogenesis of Long Non-Coding RNA TUG1 in Human Cholangiocarcinoma
Xu, Y., Leng, K., Li, Z., Jiang, X., Cui, Y.
Oncotarget, 2023, 14, pp. 779

Retraction

0 citations

Application of Normothermic Regional Perfusion in Controlled Donation After Cardiac Death Liver Transplant Donors
Zou, X., Huang, Z., Shi, W., Cui, Y., Zhong, X.
China Journal of General Surgery, 2023, 32(7), pp. 1087–1096

Open access

1 citation

Exosomal miRNAs in the Microenvironment of Pancreatic Cancer
Zou, X., Huang, Z., Guan, C., Xu, Y., Zhong, X.
Clinica Chimica Acta, 2023, 544, 117360

Open access

1 citation

Conclusion:

Prof. Xiangyu Zhong is undoubtedly a strong contender for the Best Researcher Award due to his extensive research contributions, leadership in collaborative efforts, and impact on medical and therapeutic advancements. While there are areas where improvement could further elevate his profile, such as increasing citations and expanding clinical research involvement, his overall academic impact, innovation, and leadership make him a deserving candidate. His work not only contributes to fundamental science but also holds significant promise for improving patient care and treatment outcomes, which is at the core of the Best Researcher Award’s mission.